MedTrace Logo

Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus

NCT01316861 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 79

Last updated 2013-09-25

No results posted yet for this study

Summary

The Purpose of This Study is to Evaluate the Efficacy and Safety of Acarbose in Type 2 Diabetic Patients Using Two Different Formulations of Acarbose 50mg.

Conditions

Interventions

DRUG

EMS Acarbose

EMS Acarbose 50 mg 3 times a day

DRUG

Bayer Acarbose

Bayer Acarbose 50 mg 3 times a day

Sponsors & Collaborators

  • EMS

    lead INDUSTRY

Principal Investigators

  • Felipe Pinho, MD · EMS S/A

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-09-30
Primary Completion
2013-03-31
Completion
2013-05-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01316861 on ClinicalTrials.gov